Pharmaceutical Manufacturing: Performance Metrics Enable Gap Analyses and Improvement Opportunities
"Pharmaceutical Manufacturing: Cost, Staffing & Utilization Metrics," available at: http://www3.best-in-class.com/rr297.htm
This study reveals operational metrics at several top-performing North American pharmaceutical manufacturing plants. Some of the findings include:
-- Contract manufacturers and facilities that do some contract manufacturing have lower product margins and higher conversion costs as a percentage of total sales.
-- Considerable variation exists in performance on QC efficiency, testing errors and testing costs.
-- Major areas for potential cost savings are spending and staffing on non-value added activities. Plants with excessive staffing in non-core operations, including consumables, utilities and overhead, must evaluate whether true value addition is taking place with these personnel.
Managerial insights and benchmark metrics in this study are drawn from interviews and surveys with 11 plants at nine pharmaceutical companies. In addition to conversion cost factors, quality control efficiency and cost metrics, the report also includes:
-- Capacity utilization statistics
-- Product type metrics
-- Staffing levels by function and management responsibilities
-- Levels of automation
"A solid understanding of manufacturing costs among world-class companies is the first step in evaluating a company's own current practices," said Keith Symmers, vice president at Best Practices, LLC. "This report is the only tool of its kind that can help executives at manufacturing plants identify critical performance gaps and create a specific path for marked process improvement."
Download a summary of "Pharmaceutical Manufacturing: Cost, Staffing & Utilization Metrics" at: http://www3.best-in-class.com/rr297.htm .